This post was just published on ZYX Buy Change Alert.
Fitbit is the maker of popular health monitoring gadget Fitbit. It competes with Jawbone and Apple Watch.
The company has filed papers for an IPO. Unlike other recent technology IPOs, this company is not only profitable but supports impressive financials.
Consider working with your broker to buy 100% of full core position size in the IPO.
Caution: This is not a call to buy in the after market subsequent to IPO trading on an exchange.
You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.… Please click here or the title below to read more.
(The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers. )
April Non-farm Private Payrolls came at 213K vs. 215K consensus, whisper numbers were all over the place from 150K to 300K. Analyzing this report beneath the surface, proves that our economic analysis over the last three months was correct in that the weakness in the economic data was related to transient factors.
The main point for investors is that the report is indecisive in that it is not going to help the stock market breakout of the tight range in which it has been fluctuating.
This post was just published on ZYX Buy Change Alert.
MSFT has denied that it is pursuing a bid for CRM. In our analysis, eventually this stock will be bought by one of the bigger companies such as MSFT, IBM, SAP, and ORCL. However, over the coming months there is likely to be an opportunity to buy the stock at a lower price. Please stay tuned to the Real Time Feed of ZYX Buy Change Alert.
What To Do Now?
Those in the stock have two options to consider. Either get out right here, or continue to hold a very small quantity such as 15% of the full core position size, in case our analysis is not correct and a buyout offer materializes before there is an opportunity to get back into the stock at a lower price.… Please click here or the title below to read more.